โšกYour ready-to-use recruitment solution: IRB-compliant, SEO-optimized website that automatically routes qualified patient leads to your clinical study (14-day free trial, then $44/mo)

NCT05172726RECRUITINGIRB Ready

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Sponsored by Organon and Co

Quick Self-Assessment

See if you qualify and express your interest

Preparing your pre-screening questions...
๐Ÿ“Š
1 of 100 participants interested
1% interest

Express Your Interest Today

Interested in learning more? Complete the form below.

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Advance Medical Science

    Contribute to groundbreaking research

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel (varies by study)

  • Help Others

    Benefit future patients

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3In-person assessment if eligible
  4. 4Begin participation

About This Study

This is an open-label, multi-center, Phase 3 study to evaluate tapinarof cream, 1% in pediatric subjects with plaque psoriasis.

Who Can Participate

Inclusion Criteria

Male and female subjects ages 2 to 17 years with clinical diagnosis of chronic plaque psoriasis and stable disease for at least 3 months prior to the baseline visit
Subject with plaque psoriasis covering โ‰ฅ 3% of the BSA at screening and baseline
A PGA score of โ‰ฅ 2 at screening and baseline
Female subjects of childbearing potential who are engaging in sexual activity that could lead to pregnancy should use acceptable birth control methods
Must not be pregnant
Subject, subject's parent, or legal representative must be capable of giving written informed consent/assent

Exclusion Criteria

Psoriasis other than plaque variant
Any sign of infection of any of the psoriatic lesions
Immunocompromised at screening
Screening alanine aminotransferase (ALT) or aspartate aminotransferase (AST) โ‰ฅ2.0x the upper limit of normal (ULN)
Screening total bilirubin \> 1.5x ULN
Current or chronic history of liver disease
Current or history of cancer within 5 yea

โ“ Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility during the screening process.

Study Details

๐Ÿ“‹

Study Type

INTERVENTIONAL

๐Ÿ‘ฅ

Target Enrollment

100 participants

๐ŸŽ‚

Age Range

2 Years - 17 Years

โšง

Gender

ALL

๐Ÿข

Sponsor

Organon and Co

Study Locations

Choose your preferred location or select flexible during enrollment

Unknown

Rogers

Arkansas

Location available
View Rogers location page
Unknown

Fountain Valley

California

Location available
View Fountain Valley location page
Unknown

Rancho Santa Margarita

California

Location available
Unknown

Miami Lakes

Florida

Location available
View Miami Lakes location page
Unknown

Miami Lakes

Florida

Location available
View Miami Lakes location page
Unknown

Tampa

Florida

Location available
View Tampa location page
Unknown

Chicago

Illinois

Location available
View Chicago location page
Unknown

Indianapolis

Indiana

Location available
View Indianapolis location page
Unknown

West Lafayette

Indiana

Location available
View West Lafayette location page

๐Ÿ“ And 3 more locations available

Frequently Asked Questions

Q:What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Q:Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Q:Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Q:Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

Q:How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Still have questions? Our study coordinators are here to help.

Ready to Make a Difference?

Express your interest in this groundbreaking clinical trial

๐Ÿ”’ Secure ยท ๐Ÿฅ Expert Care

Looking for Plaque Psoriasis Treatment in Rogers?

Join others in Arkansas exploring innovative treatment options through clinical research

Plaque Psoriasis Treatment Options in Rogers, Arkansas

If you're searching for Plaque Psoriasis treatment in Rogers, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Rogers, Fountain Valley, Rancho Santa Margarita and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Plaque Psoriasis. All study-related care is provided at no cost to participants.

Local Sites
3 locations in Arkansas
Now Enrolling
Up to 100 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Plaque Psoriasis?

Potential Benefits

  • โœ“Access to new treatment approaches before public availability
  • โœ“Close monitoring by experienced medical professionals
  • โœ“Study-related care provided at no cost
  • โœ“Contribute to medical research for Plaque Psoriasis

What to Expect

  • โ†’Initial screening to determine eligibility
  • โ†’Regular check-ups and monitoring visits
  • โ†’Possible compensation for time and travel
  • โ†’You can withdraw at any time

Frequently Asked Questions About This Plaque Psoriasis Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT05172726. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.